1092-1560 mg q 6 months corresponds to which Paliperidone palmitate formulation?

1092-1560 mg q 6 months corresponds to which Paliperidone palmitate formulation?

• A. Paliperidone palmitate 3-monthly
• B. Paliperidone palmitate 1-monthly
• C. Paliperidone palmitate 6-monthly
• D. Aripiprazole Maintena

Answer: (C)

Long-acting paliperidone palmitate comes in three injectable schedules, and the total dose matches how often you give the shot. The six-monthly version is given every six months and uses a large total dose per injection, typically in the range of about 1092 to 1560 mg. So a dose interval of six months with that mg range fits the six-monthly formulation, known clinically as the six-monthly paliperidone palmitate product (Hafyera). This differs from the monthly version (smaller, monthly doses) and the three-monthly version (written for every 3 months). Aripiprazole Maintena is a different medication entirely, not a paliperidone palmitate product.

Long-acting paliperidone palmitate comes in three injectable schedules, and the total dose matches how often you give the shot. The six-monthly version is given every six months and uses a large total dose per injection, typically in the range of about 1092 to 1560 mg. So a dose interval of six months with that mg range fits the six-monthly formulation, known clinically as the six-monthly paliperidone palmitate product (Hafyera). This differs from the monthly version (smaller, monthly doses) and the three-monthly version (written for every 3 months). Aripiprazole Maintena is a different medication entirely, not a paliperidone palmitate product.